Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA device-related FY 1999 appropriations

This article was originally published in The Gray Sheet

Executive Summary

Report adopted 25-19 by the House Appropriations Committee June 16 sets FY 1999 funding for salaries and expenses at $148.5 mil., up 3.5% from $143.5 mil. in FY 1998. A companion measure adopted by the Senate Appropriations Committee on June 11 freezes spending at the current level. Overall, the House bill increases FDA funding for salaries and expenses in FY 1999 by 1.6%, from $857.5 mil. to $871.5 mil., not including user fees. The legislation pending in the Senate keeps appropriations at the FY 1998 level, exclusive of an $82.9 mil. provision for rental fees to the General Services Administration for FDA facilities ("The Gray Sheet" June 15, p. 30)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010221

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel